Zymeworks buying opportunity ?
Following the major setback in 2021, Zymeworks has been actively working toward FDA approval for their drug, which they’ve now successfully secured. This approval could signal the continuation of an upward trend. I’m considering a buying opportunity around the $9 range. It’s also worth noting that they were listed on NASDAQ earlier this year. Let me know your thoughts!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.